Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$46.9M |
| 2 |
Cloudflare
NET
|
+$38.2M |
| 3 |
10x Genomics
TXG
|
+$33.7M |
| 4 |
Teladoc Health
TDOC
|
+$31.9M |
| 5 |
Pinduoduo
PDD
|
+$31.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$349M |
| 2 |
Microsoft
MSFT
|
+$191M |
| 3 |
Amazon
AMZN
|
+$136M |
| 4 |
Meta Platforms (Facebook)
META
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$73.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.42% |
| 2 | Healthcare | 14.37% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Communication Services | 10.64% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
EastGroup Properties
EGP
$11B
| $12.3M | 0.01% |
88,887
+400
| +0.5% | +$55.3K |
|
|
P
827
Everpure Inc
P
$39B
| $12.2M | 0.01% |
539,300
+1,000
| +0.2% | +$19.2K |
|
|
FOLD
828
DELISTED
Amicus Therapeutics
FOLD
| $12.2M | 0.01% |
526,600
+1,000
| +0.2% | +$20.5K |
|
829
Envista
NVST
$4.51B
| $12.1M | 0.01% |
360,000
-900
| -0.2% | -$26.1K |
|
830
First Industrial Realty Trust
FR
$8.4B
| $12.1M | 0.01% |
287,600
-700
| -0.2% | -$29.3K |
|
831
APA Corp
APA
$14B
| $12.1M | 0.01% |
853,400
-2,000
| -0.2% | -$23.3K |
|
832
Pegasystems
PEGA
$5.51B
| $12.1M | 0.01% |
181,600
| – | – |
|
833
HealthEquity
HQY
$8.83B
| $12.1M | 0.01% |
173,400
+11,600
| +7% | +$722K |
|
834
NOV
NOV
$7.36B
| $12.1M | 0.01% |
878,738
-632,434
| -42% | -$7.15M |
|
|
COR
835
DELISTED
Coresite Realty Corporation
COR
| $12.1M | 0.01% |
96,200
+10,300
| +12% | +$1.28M |
|
836
Primerica
PRI
$9.62B
| $12M | 0.01% |
89,300
-3,100
| -3% | -$389K |
|
837
MDU Resources
MDU
$4.27B
| $11.9M | 0.01% |
1,192,364
-2,892
| -0.2% | -$27K |
|
838
Ingredion
INGR
$6.63B
| $11.9M | 0.01% |
151,640
-109,100
| -42% | -$8.41M |
|
839
TG Therapeutics
TGTX
$7.34B
| $11.9M | 0.01% |
229,100
+5,100
| +2% | +$172K |
|
|
MRO
840
DELISTED
Marathon Oil Corporation
MRO
| $11.9M | 0.01% |
1,784,809
-6,400
| -0.4% | -$34.4K |
|
841
ManpowerGroup
MAN
$2.75B
| $11.8M | 0.01% |
131,300
-300
| -0.2% | -$24.7K |
|
842
Timken Company
TKR
$9.1B
| $11.8M | 0.01% |
152,800
-300
| -0.2% | -$20.4K |
|
843
Adaptive Biotechnologies
ADPT
$3.89B
| $11.8M | 0.01% |
199,600
+27,000
| +16% | +$1.39M |
|
|
MNDT
844
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $11.8M | 0.01% |
509,900
+4,800
| +1% | +$73.9K |
|
845
Cullen/Frost Bankers
CFR
$10.5B
| $11.8M | 0.01% |
134,700
| – | – |
|
|
SF
846
Stifel
SF
$12.9B
| $11.7M | 0.01% |
349,070
| – | – |
|
847
Toll Brothers
TOL
$14B
| $11.7M | 0.01% |
269,800
-3,100
| -1% | -$144K |
|
848
Landstar System
LSTR
$6.4B
| $11.7M | 0.01% |
86,800
-200
| -0.2% | -$26.2K |
|
849
Varonis Systems
VRNS
$5.26B
| $11.7M | 0.01% |
213,954
| – | – |
|
850
Texas Roadhouse
TXRH
$13.6B
| $11.7M | 0.01% |
149,200
| – | – |
|
Similar funds
Swiss National Bank's Q4 2020 Portfolio in Review
As of Q4 2020, Swiss National Bank held 2,555 positions worth $141B, up 10% from $128B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q4 2020 filing shows 125 new, 501 increased, 893 reduced and 65 closed positions. Its largest new stake was Cloudflare: 582,300 shares worth $44.2M. The largest sale was Apple, an estimated $349M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q4 2020 buy was Cloudflare: 582,300 shares worth $44.2M.
- Swiss National Bank added most to Viatris in Q4 2020, an estimated $46.9M increase.
- Swiss National Bank's biggest Q4 2020 reduction was Apple, cutting an estimated $349M.
- Swiss National Bank fully exited Immunomedics Inc in Q4 2020, selling an estimated $37.8M.
- Swiss National Bank's ten largest holdings make up 24% of its $141B portfolio in Q4 2020.
- Swiss National Bank opened 125 new positions and closed 65 in Q4 2020.
- Swiss National Bank's portfolio value rose 10% quarter-over-quarter to $141B.
Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.